跳至主要内容
临床试验/NCT06918392
NCT06918392尚未招募不适用

Field-test and Psychometric Validation of the Pectus Excavatum Evaluation Questionnaire in the Dutch Pectus Excavatum Population

Zuyderland Medisch Centrum0 个研究点目标入组 66 人开始时间: 2025年9月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
66
主要终点
Structural validity

研究概览

简要总结

A questionnaire that can measure disease severity from the patients perspective in patients with pectus excavatum already exists in English (Pectus Excavatum Evaluation Questionnaire; PEEQ). This questionnaire was recently translated into Dutch. Before this Dutch version can be used, it needs to be tested by a number of patients.

Data will be collected at three moments:

  1. Preoperatively: The PEEQ will be completed on paper during the outpatient clinic visit.
  2. Postoperatively: The PEEQ will be completed electronically 2 months post-surgery.
  3. Test-retest reliability: The PEEQ will be administered electronically at least two weeks after a previous assessment.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
12 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Eligible participants will be pectus excavatum patients aged 12 to 18 years old who are scheduled for a Nuss procedure. Parents or legal guardians will also be invited to complete the parent section of the PEEQ.

排除标准

  • Exclusion criteria will be the inability of the patient or their parent/guardian to complete the corresponding section of the questionnaire due to language barriers.

结局指标

主要结局

Structural validity

时间窗: Pre-operative assessment of pectus excavatum evaluation questionnaire at the outpatient clinic visit. Minimum score of this questionnaire is 22, maximum score is 88, a higher score indicates a lower disease-related quality of life.

A Kaiser-Meyer-Olkin (KMO) test and Bartlett's test of sphericity are performed to assess the adequacy of patient sampling before performing further structural tests. Threshold values of ≥ 0.70 in KMO test and p \< 0.05 in Bartlett's test of sphericity indicate the suitability of the collected data for factor analysis (6,7). Exploratory factor analysis (EFA), using principal axis factoring and a promax rotation method, will be conducted to identify the underlying factor structure for both the child and parent sections (8,9). These factor structures will later be subjected to confirmatory factor analysis (CFA), using polychoric correlations and robust maximum likelihood estimation, to evaluate the validity of the structures derived from EFA (8,10). Within EFA, the Kaiser criterion (eigenvalue \> 1), explained variance (≥50%), and interpretability principle will be applied to determine the number of factors to be retained. Squared multiple correlations are used to compute the communality

Internal consistency

时间窗: Pre-operative assessment of pectus excavatum evaluation questionnaire at the outpatient clinic visit. Minimum score of this questionnaire is 22, maximum score is 88, a higher score indicates a lower disease-related quality of life.

Cronbach's alpha coefficient, a measure of internal consistency, will be calculated for each subscale. A value \> .70 indicates sufficient reliability of the questionnaire for application at the group level, while a value \> .90 implies suitability for individual assessment

Test-retest reliability

时间窗: Pre-operative assessment of pectus excavatum evaluation questionnaire OR the 2 months postoperative assessment will be used as a baseline. Another assessment wil be performed minimally 2 weeks after one of the aforementioned assessments.

Test-retest reliability for each subscale will be evaluated using a two-way mixed-effects model for the intraclass correlation coefficient (ICC), type (3.1), with 95% confidence intervals reported (CI) (15). The strength of agreement will be interpreted following the guideline provided by Cicchetti (1994) (16): \< 0.40 = poor, 0.40-0.59 = fair, 0.60-0.74 = good, 0.75-1.00 = excellent. For individual items, quadratic weighted Cohen's kappa will be calculated along with its 95% to identify problematic items, with interpretation based on the standards proposed by Landis and Koch (1977) (17): \<0 = poor, 0.01-0.20 = slight, 0.21-0.40 = fair, 0.41-0.60 = moderate, 0.61-0.80 = substantial, and 0.81-.001 = almost perfect.

Responsiveness

时间窗: re-operative assessment of pectus excavatum evaluation questionnaire at the outpatient clinic visit. Minimum score of this questionnaire is 22, maximum score is 88, a higher score indicates a lower disease-related quality of life.

The responsiveness of the questionnaire will be determined using the construct approach in which preoperative and postoperative scores are compared using a paired t-test or Wilcoxon signed-rank test for skewed data. The effect size will be expressed in Cohen's d and is calculated as the mean difference divided by the standard deviation of the difference. We hypothesize that the total score on the PEEQ and mean scores per subscale improve after surgical correction of the pectus excavatum deformity as demonstrated by the original questionnaire (2,3). Responsiveness of individual items will be evaluated using a paired t-test or Wilcoxon signed-rank test, as appropriate, to guide further item refinement.

Smallest detectable change

时间窗: Pre-operative assessment of pectus excavatum evaluation questionnaire and two months postoperative assessment. Minimum score of this questionnaire is 22, maximum score is 88, a higher score indicates a lower disease-related quality of life.

The standard error of measurement (SEM) quantifies the precision of the scores across different time points and is calculated as (18): SEM = squareroot of MSE Where: · Mean square error (MSE) is the error term obtained from repeated measures ANOVA The SDC represents the minimum change in points a patient must score on the questionnaire over time to ensure the observed change reflects a real change and not a measurement error. The SDC is expressed in points on the PEEQ and will be calculated for the mean scores per subscale, and the total scores of the child's section, parent's section and entire questionnaire. The SDC at a 95% confidence level will be calculated as (18): SDC = 1.96 x square root of 2 x SEM Where: * 1.96 is the z-score corresponding to a 95% confidence level * square root of 2 x SEM accounts for the error variance from both time points

次要结局

  • Floor and ceiling effects(Pre-operative assessment of pectus excavatum evaluation questionnaire and two months postoperative assessment. Minimum score of this questionnaire is 22, maximum score is 88, a higher score indicates a lower disease-related quality of life.)

研究者

发起方
Zuyderland Medisch Centrum
申办方类型
Other
责任方
Principal Investigator
主要研究者

Erik de Loos

Principal Investigator

Zuyderland Medisch Centrum

相似试验

已完成
不适用
Assessment of Symptoms and Consequences of Coloanal Continuity ReconstructionRectal Cancer
NCT03292289Centre Oscar Lambret65
已完成
不适用
Evaluation of a Patient-Reported Symptom Index for NMIBCSuperficial Bladder Cancer
NCT03091764University of Sydney498
已完成
早期 1 期
FACBC PET and PEM as a Staging Tool and Indicator of Therapeutic Response in Breast Cancer PatientsBreast Cancer
NCT01864083Memorial Sloan Kettering Cancer Center30
Unknown
不适用
Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal CancerAnxietyFatigueNausea and VomitingNeurotoxicity SyndromeRecurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal CarcinomaStage I Ovarian Cancer AJCC v6 and v7Stage IA Fallopian Tube Cancer AJCC v6 and v7Stage IB Fallopian Tube Cancer AJCC v6 and v7Stage IC Fallopian Tube Cancer AJCC v6 and v7Stage II Ovarian Cancer AJCC v6 and v7Stage IIA Fallopian Tube Cancer AJCC v6 and v7Stage IIB Fallopian Tube Cancer AJCC v6 and v7Stage IIC Fallopian Tube Cancer AJCC v6 and v7Stage III Ovarian Cancer AJCC v6 and v7Stage III Primary Peritoneal Cancer AJCC v7Stage IIIA Fallopian Tube Cancer AJCC v7Stage IIIB Fallopian Tube Cancer AJCC v7Stage IIIC Fallopian Tube Cancer AJCC v7Stage IV Fallopian Tube Cancer AJCC v6 and v7Stage IV Ovarian Cancer AJCC v6 and v7Stage IV Primary Peritoneal Cancer AJCC v7
NCT01372787Gynecologic Oncology Group103
招募中
不适用
Development and Assessment of The Polycystic Liver Disease Questionnaire (PLD-Q).Polycystic Liver Disease
NCT02173080Mayo Clinic544